Detalhe da pesquisa
1.
Better resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review.
Br J Cancer
; 116(3): 287-292, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28006819
2.
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions.
Ann Oncol
; 28(4): 711-717, 2017 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28327917
3.
Neoadjuvant chemotherapy in ovarian cancer revisited.
Ann Oncol
; 27 Suppl 1: i30-i32, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27141067
4.
Formation of a thermally stable bilayer of coadsorbed intact and deprotonated thymine exploiting the surface corrugation of rutile TiO2(110).
Phys Chem Chem Phys
; 18(30): 20433-42, 2016 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27402290
5.
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT study.
Br J Cancer
; 112(4): 660-6, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25562434
6.
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study.
Ann Oncol
; 25(7): 1320-1327, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24618151
7.
[Histological grading of epithelial ovarian cancer. Review and recommendation]. / Histologische Malignitätsgraduierung des Ovarialkarzinoms. Überblick und Empfehlung.
Pathologe
; 35(5): 497-503, 2014 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-25069848
8.
[Specialized histopathological second opinion of advanced ovarian cancer. Experiences with collectives from prospective randomized phase III studies]. / Spezialisierte histopathologische Zweitbegutachtung fortgeschrittener Ovarialkarzinome. Erfahrungen an Kollektiven aus prospektiv randomisierten Phase-III-Studien.
Pathologe
; 35(4): 355-60, 2014 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-24992975
9.
Platinum versus platinum-combination chemotherapy in platinum-sensitive recurrent ovarian cancer: a meta-analysis using individual patient data.
Ann Oncol
; 24(12): 3028-34, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24190964
10.
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer.
Ann Oncol
; 24(4): 937-43, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23104722
11.
CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial.
Br J Cancer
; 106(4): 633-7, 2012 Feb 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22240800
12.
The impact of second to sixth line therapy on survival of relapsed ovarian cancer after primary taxane/platinum-based therapy.
Ann Oncol
; 23(10): 2605-2612, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22910840
13.
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort.
Br J Cancer
; 105(7): 890-6, 2011 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21878937
14.
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer.
Br J Cancer
; 105(8): 1144-50, 2011 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21915127
15.
Intraperitoneal treatment with the trifunctional bispecific antibody Catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group.
Gynecol Oncol
; 123(1): 27-32, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21733566
16.
A phase I open-label dose-escalation study of oral BIBF 1120 combined with standard paclitaxel and carboplatin in patients with advanced gynecological malignancies.
Ann Oncol
; 21(2): 370-375, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19889612
17.
Sequential chemotherapy with carboplatin followed by weekly paclitaxel in advanced ovarian cancer: results of a multicenter phase II study of the northeastern German society of gynecological oncology.
Gynecol Oncol
; 116(3): 317-22, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19959213
18.
[Central pathology review. Inclusion criterion for clinical studies of ovarian carcinomas?]. / Histopathologische Zweitbegutachtung. Einschlusskriterium für klinische Studien bei Ovarialkarzinomen?
Pathologe
; 29 Suppl 2: 157-9, 2008 Nov.
Artigo
em Alemão
| MEDLINE | ID: mdl-18726596
19.
Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: a prospective phase II study of the Arbeitsgemeinschaft Gynäekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut).
Gynecol Oncol
; 107(3): 518-25, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17910981
20.
[Peritoneal carcinomatosis in ovarian cancer. Methods and treatment results]. / Peritoneal metastasiertes Ovarialkarzinom. Vorgehensweise und Behandlungsergebnisse.
Chirurg
; 78(12): 1111-6, 2007 Dec.
Artigo
em Alemão
| MEDLINE | ID: mdl-17994201